002821.SZ
002821.SZ
CNE100002BZ6
ASYMCHEM
Loading chart...

Company Profile

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, including antibody-peptide conjugates; formulation CDMO; clinical CRO; synthetic biology and new technology output business. The company also engages in key pharmaceutical intermediates, APIs, and formulations activities. The company was founded in 1998 and is headquartered in Tianjin, China.

Related stocks

6821.HK
6821.HK • China
ASYMCHEM
155.1 HKD
7.15B USD 1Y +60.9%
688331.SS
688331.SS • China
REMEGEN CO LTD
107.86 CNY
9.11B USD 1Y +4.2%
688428.SS
688428.SS • China
INNOCARE PHARMA LTD
28.12 CNY
7.44B USD 1Y +5.2%
6990.HK
6990.HK • China
SKB BIO
444.6 HKD
13.54B USD 1Y -12.9%
9926.HK
9926.HK • China
AKESO
109.1 HKD
12.81B USD 1Y -17%
002653.SZ
002653.SZ • China
HAISCO PHARMA
61.02 CNY
10.42B USD 1Y +15.3%
002252.SZ
002252.SZ • China
SHANGHAI RAAS
5.06 CNY
4.99B USD 1Y -25.4%
688578.SS
688578.SS • China
SHANGHAI ALLIST PHARMACEUTICALS
82.5 CNY
5.56B USD 1Y -23%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
48.2% p.a.
Max Drawdown (5Y)
-84.0%
Sharpe Ratio (5Y)
-0.25
Beta Factor
0.19
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 60.7 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (48.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -84.0% in the extended horizon.
ende